🇸🇪 Sweden Country × Condition
multiple myeloma Clinical Trials in Sweden
Active clinical trials for multiple myeloma with research sites in Sweden. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇸🇪 Sweden
Active Trials in Sweden (2)
NCT06616389 Phase 1, Phase 2
Recruiting
Study of ODX (OsteoDex) in Multiple Myeloma
Enrollment
12 pts
Country
🇸🇪 Sweden
DexTech Medical AB
View Trial → NCT04558931 Phase 2
Recruiting
Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma
Enrollment
62 pts
Country
🇸🇪 Sweden
Karolinska Institutet
View Trial → Frequently Asked Questions
How many multiple myeloma clinical trials are active in Sweden?
There are currently 2 active clinical trials for multiple myeloma with sites in Sweden, of which 2 are actively recruiting patients.
How can I join a multiple myeloma clinical trial in Sweden?
To join a multiple myeloma clinical trial in Sweden, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Sweden directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple myeloma trials in Sweden?
Active multiple myeloma trials in Sweden span Phase 1, Phase 2, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.